ClinicalTrials.Veeva

Menu

Cardiac Autonomic Denervation for Cardio-inhibitory Syncope (CardioSync)

U

University of Sao Paulo General Hospital

Status

Not yet enrolling

Conditions

Syncope, Vasovagal
Bradycardia; Syncope

Treatments

Procedure: Electrophysiological study and bi-atrial Ganglionated Plexi ablation
Procedure: Electrophysiological study and Right side Ganglionated Plexi ablation
Procedure: Electrophysiological study

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT05572034
UAP 174

Details and patient eligibility

About

Background: Autonomic system modification is an established therapeutic approach that has been increasingly used for the treatment of vagal-related symptomatic bradycardia, such as cardio-inhibitory vasovagal syncope1-12.

Although convincing results had been reported from small populations, a large randomized study providing robust evidence on the efficacy of this approach has not yet been performed.

Hypothesis: Cardiac autonomic system modification is effective for the treatment of vagal-related symptomatic bradycardia, and is associated better clinical results as compared to placebo.

Enrollment

45 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Aged between 18 and 70 years old.
  • Cardio-inhibitory response (VASIS 2A or 2B) during tilt test, or after carotid sinus massage.
  • Patients with bradycardia mediated by vagal hypertonia documented on 24-hour Holter monitoring and a clear relationship with symptoms.

Exclusion criteria

  • Ages under 18 and over 70
  • Presence of structural heart disease documented by echocardiography.
  • Hypothyroidism and hyperthyroidism, drug effects, obstructive sleep apnea and other causes of secondary bradycardia.
  • Anatomical disease of the conduction system.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

45 participants in 3 patient groups

Group A
Sham Comparator group
Description:
A diagnostic electrophysiological study will be performed in patients of group A
Treatment:
Procedure: Electrophysiological study
Group B
Active Comparator group
Description:
A electrophysiological study with cardiac denervation, with right Ganglionated Plexi ablation exclusively will be performed in patients of group B
Treatment:
Procedure: Electrophysiological study and Right side Ganglionated Plexi ablation
Group C
Active Comparator group
Description:
A electrophysiological study with cardiac denervation, with right and left Ganglionated Plexi ablation will be performed in patients of group C.
Treatment:
Procedure: Electrophysiological study and bi-atrial Ganglionated Plexi ablation

Trial contacts and locations

2

Loading...

Central trial contact

Mauricio I scanavacca, MD, PhD; Esteban W Rivarola, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems